Arie and Dan Belldegrun

Arie and Dan Bellde­grun are build­ing biotech cam­pus­es around the globe — with a new­ly raised $3B fund to keep the dirt fly­ing

The biotech sec­tor on Nas­daq may have been blight­ed by im­plod­ing stock prices, the gen­er­al­ists long gone in search of green­er fields as the bears …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.